Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 4,200 shares at $87.80 ($372K) on 2017-06-09, disclosed to the SEC on 2017-06-12.
Open-market sale of $372k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.80 | 2,502 | $220K | 59.0% |
| 2 | $89.76 | 1,698 | $152K | 41.0% |
| Total | $88.59 avg | 4,200 | $372K | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-07-11 | $906K | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |